Magnetic resonance imaging (MRI) is a noninvasive imaging technology that provides your doctor with a three-dimensional, detailed anatomical image, typically of a specific part of your body, that’s ...

Researchers at University College London have developed a new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis ...

New imaging research from Western University (London, Canada) has demonstrated that a magnetic resonance imaging (MRI) approach called quantitative susceptibility mapping (QSM) can be an important ...

One of the uncomfortable truths about multiple sclerosis is that the part of the brain likely to reveal the most about the disease and how a patient will be affected has been mostly invisible to ...

Radiomics offers improved assessment of spinal cord pathology in MS, surpassing conventional MRI in precision and sensitivity. A study identified 12 significant radiomic features, with four ...

For patients with pediatric-onset multiple sclerosis (POMS), social determinants of health (SDOH) are associated with worse brain magnetic resonance imaging (MRI) outcomes, according to a study ...

AI-based image processing revealed cortical lesions that were largely invisible on standard MRI scans in patients with multiple sclerosis (MS), new research showed. Researchers combined multiple ...

Treatment-naïve POMS patients receiving rituximab demonstrated near-complete relapse suppression after drug activity was established, supporting early high-efficacy B-cell depletion strategies in ...

BOSTON — A new generic version of glatiramer acetate for multiple sclerosis (MS) has shown similar results to the branded agent (Copaxone, Teva Pharmaceuticals) in terms of reduction in lesions on ...